Ridgecrest Wealth Partners, LLC Merck & Co., Inc. Transaction History

Ridgecrest Wealth Partners, LLC

$166 Million
Q2 2024

A detailed history of Ridgecrest Wealth Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ridgecrest Wealth Partners, LLC holds 11,272 shares of MRK stock, worth $1.24 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares

11,272

Previous 11,272 -0.0%

Holding current value

$1.24 Million

Previous $1.49 Million 6.19%

% of portfolio

0.84%

Previous 0.89%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 09, 2024	SELL	$100.18 - $109.02 $300 - $327	-3 Reduced 0.03%	11,272 $1.23 Million
Q3 2023 Oct 25, 2023	SELL	$102.95 - $114.33 $25,737 - $28,582	-250 Reduced 2.17%	11,275 $1.16 Million
Q2 2023 Jul 31, 2023	BUY	$108.61 - $118.38 $49,308 - $53,744	454 Added 4.1%	11,525 $1.33 Million
Q4 2022 Jan 26, 2023	SELL	$87.44 - $112.11 $4,372 - $5,605	-50 Reduced 0.45%	11,071 $0
Q3 2022 Oct 20, 2022	SELL	$84.53 - $94.96 $735,411 - $826,152	-8,700 Reduced 43.89%	11,121 $958,000
Q2 2022 Jul 29, 2022	SELL	$83.49 - $94.64 $39,490 - $44,764	-473 Reduced 2.33%	19,821 $1.81 Million
Q1 2022 Apr 26, 2022	SELL	$73.51 - $82.4 $30,139 - $33,784	-410 Reduced 1.98%	20,294 $1.67 Million
Q4 2021 Jan 19, 2022	BUY	$72.28 - $90.54 $25,298 - $31,689	350 Added 1.72%	20,704 $1.59 Million
Q3 2021 Nov 03, 2021	BUY	$71.68 - $78.83 $6,307 - $6,937	88 Added 0.43%	20,354 $1.53 Million
Q2 2021 Jul 21, 2021	BUY	$70.31 - $77.77 $79,309 - $87,724	1,128 Added 5.89%	20,266 $1.58 Million
Q1 2021 May 19, 2021	BUY	$68.86 - $81.11 $1.32 Million - $1.55 Million	19,138 New	19,138 $1.48 Million

Others Institutions Holding MRK

# of Institutions

3,826

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $278B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ridgecrest Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ridgecrest Wealth Partners, LLC with notifications on news.

Account

Ridgecrest Wealth Partners, LLC Merck & Co., Inc. Transaction History